A detailed history of Bank Of New Hampshire transactions in Organon & Co. stock. As of the latest transaction made, Bank Of New Hampshire holds 66 shares of OGN stock, worth $1,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66
Previous 66 -0.0%
Holding current value
$1,340
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

BUY
$19.27 - $24.63 $443 - $566
23 Added 53.49%
66 $1,000
Q4 2022

Jan 10, 2023

SELL
$23.31 - $28.61 $2,074 - $2,546
-89 Reduced 67.42%
43 $1,000
Q3 2022

Oct 24, 2022

SELL
$23.4 - $34.25 $9,360 - $13,700
-400 Reduced 75.19%
132 $3,000
Q2 2022

Jul 08, 2022

BUY
$31.66 - $38.9 $16,843 - $20,694
532 New
532 $18,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.